In a healthy subject, ammonia produced in the body is excreted by the kidney in the form of urea, the product of the urea cycle (1), or converted into substances useful for the body.
The dose of drug was expressed in terms of the salt, -if it is applicable, in this paper : The hydrochloride for L-ornithine, and the potassium and magnesium salts in 4: 6 mixture for L-aspartic acid.
METHODS

1) Acute toxicity
L-Ornithine L-aspartate in 10% solution was given to male mice of ddY strain, 7 to 8 week old, 25 to 30 g of body weight, to determine the acute toxicity. After administra tion of the solution orally, subcutaneously and intraperitoneally the symptoms and the death rate were recorded up to 72 hours. The same observation was carried out with the mice given 5% solution of the compound intravenously.
2) Infusion of L-ornithine L-aspartate in dogs
Influences of continuous infusion of 5% solution of L-ornithine L-aspartate were examined in dogs upon blood pressure, respiration, electrocardiogram, and blood levels of sodium and potassium.
Four healthy dogs, 10 to 13 kg of body weight, were employed. The dog was anesthetized with pentobarbital sodium, 40 mg/kg given intravenously.
Blood pressure and respiratory movement were recorded on a smoked paper from the femoral artery and the cannulated trachea, respectively. Electrocardiograms were obtained through leads I and III and chest lead by means of a thermoelectric recorder.
The blood electrolytes were determined with a flame photometer of Beckmann type.
The values obtained at 30 minute intervals after institution of infusion were compared with control values. The rate of infusion of L-ornithine L-aspartate solution was adjusted to 100 ml/hr, and the infusion was continued for 4 hours, or 400 ml in total.
3) Effects upon ammonia intoxication a) Effects upon muscular paralysis due to ammonia Male mice of ddY strain, 5 weeks of age, were employed. Solutions of L-ornithine L-aspartate, L-ornithine and L-aspartic acid were injected into the mice intraperitoneally in 0.1 ml/10 g after the concentration was adjusted depending on the dose to be ad ministered. After an interval of an hour each animal received ammonium chloride, 500 mg/kg, intraperitoneally, and 3 minutes later the animal was placed on a saran net of 15 mesh which was held at an angle of about 70° against the horizontal plane. The time required for the animal slipping down more than 15 cm on the sloped screen was measured, the time being referred to as the paralysis time.
b) Effects upon acute toxicity of ammonium acetate Male mice of ddY strain, 5 week old, were deprived of food for 14 hours and received intraperitoneal injection 0.1 ml/10 g of L-ornithine L-aspartate, L-aspartic acid or L ornithine solution adjusted to pH 7.4 with a phosphate buffer. After an interval of an hour they received LD 50 of ammonium acetate, 880 mg/kg, intraperitoneally.
The number of dead animals in each group was recorded together with that of control group pretreated with the phosphate buffer solution. c) Effects upon acute toxicity of ammonium chloride Male mice of ddY strain, 5 weeks of age, were given L-ornithine L-aspartate, L aspartic acid or L-ornithine in a dose of 100 mg/kg intraperitoneally. After an interval of half an hour they received intraperitoneal injection of 630, 662, 695, 730, 766, 804, or 844 mg/kg of ammonium chloride. The death rate in each group was recorded 24 hours after administration of ammonium chloride. Each drug solution was so adjusted as to make the volume injected 0.1 ml/10 g and the same volume of physiological saline was used in control group.
d) Effects upon blood ammonia level and urea formation
Healthy male rabbits, 2 to 2.5 kg of body weight, were anesthetized with pento barbital sodium given intravenously. The animal was fixed on its back, and the bilateral renal arteries and veins were ligated simultaneously through an incision in order to exclude the urea excretion by kidney. L-Ornithine L-aspartate, L-aspartic acid or L ornithine in 300 mg/kg was injected into an ear vein, and after a 3 minutes interval 100 mg/kg of ammonium chloride was given intravenously. Each drug solution was so adjusted as to make the volume injected 1 ml/kg. Blood samples were collected from an intact ear vein before (0 min) and at 5th, 10th, 20th and 60th minute after ammonium chloride administration. In order to prevent blood coagulation the syringe was hepari nized. Whole blood was analyzed for ammonia and the plasma for urea.
Determination of blood ammonia level: A microdiffusion apparatus of Conway type being kept in an incubater of 36°C was taken out 4 minutes after blood sampling. In the inner chamber was placed 1 ml of N/150 H2SO4j and in the outer chamber 0.5 ml of the blood and 1 ml of saturated K2CO3 solution without mixing. Onto the apparatus a cover greased with vaseline and paraffin (3: 1, m.p. 55°C) was placed tightly. Exactly 5 minutes after sampling the blood, the apparatus was rotated once a second for 15 seconds to mix the K2CO3 solution and the blood. The mixture was kept at 36±0.5°C for 20 minutes to allow ammonia to diffuse. The acid solution in the inner chamber was transferred to an ice-cooled, glass-stoppered test tube with a capillary pipette. The inner chamber was washed with five portions of 0.2 ml of distilled water, and the wash ings were added to the acid solution. To the test tube, under ice-cool, were added 0.05 ml of 0.03 M MnSO4, 1 ml of alkaline phenol solution prepared freshly (phenol 25 g, 5 N-NaOH 54 ml, filled up to 100 ml with distilled water), and 0.5 ml of sodium hypo chlorite (effective chlorine 1.4%), in the order named. The test tube was stoppered, the content was gently mixed, heated in a boiling bath for 5 minutes, and then cooled in ice water for 2 minutes. Depending on the coloring, the solution was diluted with a suitable amount of:. distilled water, kept at a room temperature for 20 minutes, and subjected to colorimeter at 610 m,u. Standard curve for colorimetry was prepared each time.
Determination of blood urea level: One tenth milliliter of plasma was freed of protein by addition of 1.5 ml of distilled water and 1.4 ml of 10% solution of trichloroacetic acid, mixing, and centrifugation at 3,000 r.p.m. One milliliter of the supernatant was trans ferred to a brown, glass-stoppered test tube, to which were added 2.1 ml of distilled water, 1.0 ml of 101o diacetylmonoxime solution and 1.0 ml of conc. HCl, and mixed well. The solution was subjected to colorimetry at 480 m,u after heating in a boiling bath for 40 minutes and cooling in cold water. 4) Effects upon hepatotoxicity of carbon tetrachloride Seventy-five male mice of ddY strain, 5 week old, were diveded into 5 groups of 15 animals. They took CE-2 diet and water in a room where the temperature was 24±2°C and the humidity 50 to 65%. Each group received one of the following treatments: 1) carbon tetrachloride inhalation and L-aspartic acid 100 mg/kg, 2) carbon tetrachloride inhalation and L-ornithine 100 mg/kg, 3) carbon tetrachloride inhalation and L-ornithine L-aspartate 200 mg/kg, 4) carbon tetrachloride inhalation and physiological saline, and 5) physiological saline alone. Everyday each animal was placed in a cage saturated with carbon tetrachloride vapor after body weight measurement and oral administra tion of drug in the amount of 0.1 ml/10 g. Saturation of the cage was carried out by covering the cage made of aluminum (20 x 35 X 20 cm) with a sheet of vinyl resin and placing a Petri dish (9 cm diameter) containing 30 ml of carbon tetrachloride under the floor mesh for 5 minutes. The duration of inhalation, i.e., the time of keeping the animal in the cage, was 7 minutes once a day for the first 7 days, 7.5 minutes for the second 9 days, 8 minutes for the third 1 day, and 8 minutes for the last 7 days, how ever, twice a day. Thus a series of inhalation experiment consisted of 24 days.
Body weight of animal was measured everyday previous to inhalation of carbon tetrachloride. When the inhalation was once a day the measurement was carried out at about 10 a.m. and when twice a day at about 10 a.m. and 3 p.m.
BSP excretion test was carried out with 5 mice of each group on the next day of the final inhalation of carbon tetrachloride. BSP in 50 mg/kg was injected into the tail vein, and after a 30 minute interval blood sample was obtained from the jugular vein with heparinized syringe. The plasma separated by centrifugation of the blood at 3,000 r.p.m. was transferred to 2 test tubes A and B in an amount of 0.1 ml each, and diluted 40 times with physiological saline. To test tube A was added 0.05 ml of 10% NaOH solution and to test tube B 0.05 ml of 10% HCl solution. The color developed was measured at 570 mp, and the transmittance of solution in test tube A was contrasted with that of solution in test tube B. In this test the values smaller than 1.0 mg/dl were considered normal.
Six mice of each group were subjected to measurement of serum GOT and GPT activities according to Reitman-Frankel's method.
The animals used measurement of transaminase activity were killed by dislocation of the cervical vertebrae after blood sampling, and the livers were immediately isolated for weighing with torsion balance. The weight of the liver was expressed as wet weight mg/body weight g. The animals used in BSP test were likewise killed by cervical dis location and frozen with dry ice for more than 10 hours. The frozen animal was gradually thawed in a Petri dish, on a sheet of saline-soaked gauze, the liver was excised for weighing, and blood streaks were cleaned with a piece of dry filter paper.
The liver obtained from the frozen animal as described above was ground with 5 times amount of anhydrous sodium sulfate, packed into a filter paper thimble and ex tracted with 120 ml of ether for 1 hour in a Soxhlet extractor, the reflux rate of ether being adjusted to 5.5 minutes. The ether extract was evaporated to a mass at about 80°C for 12 hours. The weight of the residual mass cooled in a desiccator was con sidered as the lipid content in the liver.
A portion of the liver obtained from the animal used in measurement of serum trans aminase activity was quickly fixed with 20% formalin. The preparation was examined with special reference to perilobular fatty degeneration, cellular infiltration in Glisson's capsules, and central necrosis in lobules.
RESULTS
1) Acute toxicity
Slight decrease in spontaneous movement of the mice receiving oral administration of L-ornithine L-aspartate was noticed for a short period of time following medication. No other abnormal behaviors and no death were recorded in all groups throughout the experiment. The results are summarized in Table 1 . The results are shown in Table 2 .
As evidenced by the table, plasma levels of sodium and potassium negligibly decreased during infusion and the ratio Na/K remains almost unchanged. Table 3 , where the animals pretreat ed with physiological saline serve as control.
Delay onset of ammonia paralysis, i.e., larger value of the paralysis time is considerable in the group pretreat ed with L-ornithine L-aspartate, and the delay is more remarkable as the dose is increased. (mEq/1) c) Effects upon acute toxicity of ammonium chloride The results given in Fig. 1 indicate that all kinds of drug pretreatments reduce the toxicity of ammonium chloride in mice, and L-ornithine and L-ornithine L-aspartate are more effective than L-aspartic acid in this respect.
FIG. 1. Effects of L-ornithine L-aspartate upon the toxicity of ammonium chloride, mortality in mice (ddY).
This figure shows that drug pretreatments reduce the toxicity of ammonium chloride in mice, and L-ornithine L-aspartate is most effective among three drugs.
Each drug in a dose of 100 mg/kg was administered intrap°ritoneally 30 minutes prior to the intrap2ritoneal injection of ammonium chloride, and each mortality was based on the result with 10 animals.
FIG. 2. Effects of L-ornithine L-aspartate upon the increase in the blood ammonia
level after 100 mg/kg of ammonium chloride in the rabbit with the renal vessels l igated.
d) Effects upon blood ammonia level and urea formation
Each group consisted of 3 to 7 rabbits. Average increases in blood levels of am monia and urea after 100 mg/kg of ammonium chloride administration, are given in In the animals that were given no ammonium chloride, the blood ammonia level remained almost unaltered and the level of urea increased by only 2.1 mg/dl 60 minutes after drug administration in average. No significant difference among groups is seen in Table 5 . 
4) Effects upon hepatotoxicity of carbon tetrachloride
As shown in Fig. 4 of mean body weight change, weight loss was noted in control group in which no drug treatment was allocated but carbon tetrachloride inhalation. In Tables 6-11 abbreviations were used as follows :
(1) Asp. CCI, : group inhaled CC14 and administered L-aspartic acid 100 mg/kg/day orally. (4) CC14 : group inhaled CC14 and administered physiological saline solution 0.1 ml/ 10 g/day orally.
(5) Normal : group administered physiological saline solution 0.1 ml/10 g/day orally.
As shown in Table 7 , transaminase activity of all groups that inhaled carbon tetra chloride is higher than that of normal group without inhalation. GPT activity of all groups pretreated with drug is lower than that of control group without drug pretreat ment. GOT activity of both groups of L-ornithine and L-ornithine L-aspartate is some what lower than that of L-aspartic acid group, although the difference is not significant. (Karmen unit/ml serum) TABLE 8. Liver weight mg/body weight g in the mice that inhaled carbon tetrachloride and used in Table 6.   TABLE 9 . Liver weight mg/body weight g in the mice that inhaled carbon tetrachloride, and used in Table 7 .
The values, liver weight mg/body weight g, were shown in Tables 8 and 9 . The difference in the liver weight between directly measured and indirectly measured groups seems due to the difference in the degree of dehydration.
Among the groups that in-,, haled carbon tetrachloride, those pretreated with L-aspartic acid and L-ornithine exhibit slightly larger values than the other groups although not significant.
The value, lipid/liver weight, is shown in Table 10 . No significant difference is noticed among the values of all groups that inhaled carbon tetrachloride. Table 11 shows the histologic findings in the mice inhaled carbon 'tetrachloride.
In some animals pretreated with one of the drugs, the central necrosis in lobules are less marked than in control animals without drug pretreatment. 
DISCUSSION
As stated in the introduction, it is known that when NH3 level in blood is elevated owing to disturbances of metabolism, hepatic coma is induced and metabolic disorder is still more enhanced. As the consequence, appreciable correlation can be found between blood NH3 level and EEG change or mental disorder (26, 27) . There is further cor relation between toxicity of NH3 and pH of blood, the toxicity being increased when blood inclined to alkaline (28) . In this case, NH3 will pass through the cell membrane more easily, and subsequently blood-brain barrier or the like is assumed to be destroyed to facilitate the invasion of the brain by NH3 (29) . Salvatore et al. (30) observed that when NH,-salt was intraperitoneally given, blood NH3 level was sharply elevated within 5 minutes, accompanied by simultaneous rise in cerebral concentration of NH3. In hepatic coma, respiratory alkalosis frequently takes place (31) , which is considered to be due to the stimulation of the respiratory center by produced NH3. In this way, a vicious circle is initiated by elevation of blood NH3 level. Furthermore, normal meta bolism of NH3 and TCA cycle is impeded, enabling the tissue degeneration to occur. In order to cut this circle, it is clinically important to lower blood NH3 level by some means. In the present experiments, L-ornithine L-aspartate was found to have clinical value in reducing toxicity of NH3 and accelerating the formation of urea. As for the fate of NH3 in the living body, formation of urea through the urea cycle, formation of glutamine, incorporation into muscle and amino acid and direct excretion from the kidney are considered. Because it was confirmed in the present experiments that blood NH3 level was lowered and at the same time urea formation was accelerated in rabbits with ligature of the renal vessel, the principal actions of L-ornithine L-aspartate are considered to be activation of the urea cycle. However, there is also possibility that they may activate some other detoxicating system, if it is assumed that a minute doses of them are sufficient to activate the urea cycle catalytically, because positive correlation was observed between the doses and responses in the experiment on muscular paralysis due to ammonia. Further, L-ornithine produces L-glutamic acid by means of ornithine-o-transaminase, and also L-aspartic acid, through GOTM shunt, takes a-ketoglutaric acid out of the TCA cycle as L-glutamic acid and incorporates carbohydrate into the cycle. Therefore these chemicals are considered to affect the carbohydrate and fat metabolism, and to have favorable effect on protein synthesis by converting L-glutamic acid into nonessential amino acids, and activate the production of ATP. All these action, together with ac tivation of the urea cycle are assumed to exert therapeutic effect on the CCI,-caused hepatic disorder.
SUMMARY
Pharmacologic study on L-ornithine L-aspartate was carried out with following results.
1. LD 50 of L-ornithine L-aspartate for mice of ddY strain were more than 5 g/kg orally, subcutaneously, or intraperitoneally, and more than 2 g/kg intravenously. 2. No abnormal findings were observed in blood pressure, respiratory movement, pulse rate, electrocardiogram and plasma sodium and potassium concentrations of dogs receiving continuous intravenous infusion of 5% solution of L-ornithine L-aspartate at 100 ml/hr. 3. In ddY mice the time required for development of muscular paralysis after intraperitoneal injection of ammonium chloride, 500 mg/kg, was prolonged by pretreat ment with L-ornithine L-aspartate. 4 . In ddY mice large doses of ammonium acetate or ammonium chloride given intraperitoneally caused convulsion and death. Pretreatment with L-ornithine L-aspartate reduced the incidence of convulsion and death. In other words, L-ornithine L-aspartate effectively attenuated the toxicity of ammonium ion. L-Ornithine L-aspartate was more effective in this respect than L-ornithine or L-aspartic acid alone in the same dose.
5. Blood samples for analyses of ammonia and urea were obtained from the rabbit whose renal vessels were ligated under pentobarbital anesthesia. After control period the animal received one of L-ornithine L-aspartate, L-ornithine and L-aspartic acid in 300 mg/kg intravenously, and after 5 minute interval 100 mg/kg of ammonium chloride was givenn intravenously. Blood samples collected after drug administration were like wise analyzed for ammonia and .urea. As compared with the values in control animals receiving only ammonium chloride, disappearance of blood ammonia and formation of urea were facilitated by pretreatment with the above-named drugs, and particularly the effect of L-ornithine L-aspartate was remarkable.
6. The mice of ddY strain were daily given orally 200 mg/kg of L-ornithine L aspartate, inhaled carbon tetrachloride vapor for a definite period of time, and weighed everyday for 24 days. On the 25th day of experiment they were subjected to BSP ex cretion test, determination of serum GPT and GOT activities and histologic examina tion of the liver. Weight loss was recorded in control group whereas weight gain was noted in the group on L-ornithine L-aspartate, the difference in body weight change being significant between control and medicated groups. BSP value in the medicated group was significantly lower. GOT and GPT activities were similar in all groups and GPT activity was slightly lower in the medicated groups, although not significant. Histologic findings suggested that central necrosis in the liver lobulus was less marked in L-ornithine L-aspartate group than in control group. The same examinations were performed in the animals pretreated with either L-ornithine or L-aspartic acid, and the results resem bled those obtained in the animalson L-ornithine L-aspartate.
